Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace
Michael H. Baumann, Susruta Majumdar, Valerie Le Rouzic, et al.
Neuropharmacology (2017) Vol. 134, pp. 101-107
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

New psychoactive substances: a review and updates
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 235
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 210
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 44
Fentanyl and its derivatives: Pain-killers or man-killers?
Jiří Patočka, Wenda Wu, Patrik Olekšák, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e28795-e28795
Open Access | Times Cited: 12
Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
Renata Solimini, Simona Pichini, Roberta Pacifici, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 70
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 20
A Case Study Involving U-47700, Diclazepam and Flubromazepam—Application of Retrospective Analysis of HRMS Data
Emma Partridge, Stephen Trobbiani, Peter Stockham, et al.
Journal of Analytical Toxicology (2018) Vol. 42, Iss. 9, pp. 655-660
Open Access | Times Cited: 53
The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning
Kirti Sharma, Tim G. Hales, V. Jayathirtha Rao, et al.
Forensic Toxicology (2018) Vol. 37, Iss. 1, pp. 1-16
Open Access | Times Cited: 53
Pharmacological Research as a Key Component in Mitigating the Opioid Overdose Crisis
Michael H. Baumann, Theresa Kopajtic, Bertha K. Madras
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 12, pp. 995-998
Closed Access | Times Cited: 52
Drug Interactions With New Synthetic Opioids
Clara Pérez‐Mañá, Esther Papaseit, Francina Fonseca, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 51
In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
Marthe M. Vandeputte, Annelies Cannaert, Christophe P. Stove
Archives of Toxicology (2020) Vol. 94, Iss. 11, pp. 3819-3830
Closed Access | Times Cited: 48
Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances
Neil B. Varshneya, D. Matthew Walentiny, L Moisă, et al.
Neuropharmacology (2019) Vol. 151, pp. 171-179
Open Access | Times Cited: 46
Sex and Gender Differences in the Effects of Novel Psychoactive Substances
Liana Fattore, Matteo Marti, Rafaela Mostallino, et al.
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 606-606
Open Access | Times Cited: 46
U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
Michael H. Baumann, Graziella Tocco, Donna M Papsun, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 895-895
Open Access | Times Cited: 41
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors
Amy J. Eshleman, Shanthi Nagarajan, Katherine M. Wolfrum, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114293-114293
Closed Access | Times Cited: 39
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances
Donna M Papsun, Alex J. Krotulski, Barry K. Logan
American Journal of Forensic Medicine & Pathology (2022) Vol. 43, Iss. 4, pp. 315-327
Closed Access | Times Cited: 24
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl
Sabrine Bilel, Joaquim Azevedo Neto, Raffaella Arfè, et al.
Neuropharmacology (2022) Vol. 209, pp. 109020-109020
Open Access | Times Cited: 22
Buprenorphine: New Challenges and Opportunities
Sabrina Corrêa da Costa, Mohammad Ghafouri, Lantie Jorandby, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700
Camille Richeval, Jean‐Michel Gaulier, Ludovic Romeuf, et al.
International Journal of Legal Medicine (2018) Vol. 133, Iss. 1, pp. 133-142
Closed Access | Times Cited: 44
Mixed intoxication by the synthetic opioid U‐47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data
Katharina Koch, Volker Auwärter, Maren Hermanns‐Clausen, et al.
Drug Testing and Analysis (2018) Vol. 10, Iss. 8, pp. 1336-1341
Closed Access | Times Cited: 41
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Valeria Catalani, Davide Arillotta, John Corkery, et al.
Frontiers in Psychiatry (2021) Vol. 11
Open Access | Times Cited: 31
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom
Soumen Chakraborty, Rajendra Uprety, Amal EI Daibani, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 14, pp. 2661-2678
Open Access | Times Cited: 28
Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
Davide Arillotta, Fabrizio Schifano, Flavia Napoletano, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 31
Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine
Tanja M. Gampfer, Lea Wagmann, Yu Mi Park, et al.
Archives of Toxicology (2020) Vol. 94, Iss. 6, pp. 2009-2025
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top